We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Aker BioMarine ASA (AKBM) NOK6

Sell:55.00 NOK Buy:60.00 NOK Change: 2.10 NOK (3.97%)
Market closed |  Prices as at close on 29 February 2024 | Switch to live prices |
Sell:55.00 NOK
Buy:60.00 NOK
Change: 2.10 NOK (3.97%)
Market closed |  Prices as at close on 29 February 2024 | Switch to live prices |
Sell:55.00 NOK
Buy:60.00 NOK
Change: 2.10 NOK (3.97%)
Market closed |  Prices as at close on 29 February 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Aker Biomarine ASA is a Norway-based biotech innovator and Antarctic krill-harvesting company. It consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.

Contact details

Oksenoyveien 10,
P.O. Box 496
+47 (2) 4130000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
4.67 billion NOK
Shares in issue:
87.67 million
Packaged Foods & Meats
Oslo Stock Exchange
Norwegian Krone
Oslo All Share Index

Key personnel

  • Ola Snove
    Chairman of the Board
  • Matts Johansen
    Chief Executive Officer
  • Katrine Klaveness
    Chief Financial Officer
  • Hege Spaun
    Chief Officer People and External Affairs
  • Webjorn Barstad
    Executive Vice President - Offshore
  • Tone Lorentzen
    Executive Vice President - Supply Chain
  • Sigve Nordrum
    Executive Vice President - Animal Health and Nutrition
  • Simon Seward
    Executive Vice President - Human Health and Nutrition
  • Trond Smedsrud
    Executive Vice President - Strategic Investment

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.